Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Oesophageal adenocarcinoma (OAC) is increasingly common in the west, and survival remains poor at 10-15 % at 5 years. Immune responses are increasingly implicated as a determining factor of tumour progression. The ability of lymphocytes to recognise tumour antigens provides a mechanism for a host immune attack against cancer providing a potential treatment strategy. MATERIALS AND METHODS: Tumour infiltrating lymphocytes (TILs: CD3+, CD4+, CD8+ and FOXp3+) were assessed by immunohistochemistry using tissue microarrays in a contemporary and homogeneous cohort of OAC patients (n = 128) undergoing curative treatment. RESULTS: Multivariate analysis identified three independent prognostic factors for improved cancer-specific survival (CSS): increased CD8+ TILs (p = 0.003), completeness of resection (p < 0.0001) and lower pathological N stage (p < 0.0001). Independent prognostic factors for favourable disease-free survival included surgery-only treatment (p = 0.015), completeness of resection (p = 0.001), increased CD8+ TILs (p < 0.0001) and reduced pathological N stage (p < 0.0001). Higher levels of TILs in the pathological specimen were associated with significant pathological response to neoadjuvant chemotherapy (NAC). On multivariate analysis increased levels of CD4+ (p = 0.017) and CD8+ TILs (p = 0.005) were associated with significant local tumour regression and lymph node downstaging, respectively. DISCUSSION: Our results establish an association of TILs and survival in OAC, as seen in other solid tumours, and identify particular TIL subsets that are present at higher levels in patients who responded to NAC compared to non-responders. These findings highlight potential therapeutic strategies in EAC based on utilising the host immunological response and highlight the immune responses biomarker potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bang, Y.-J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A., Lordick, F., Ohtsu, A., Omuro, Y., Satoh, T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61121-x · Cited by 7,302
Jamieson, N. B., Mohamed, M., Oien, K. A., Foulis, A. K., Dickson, E. J., Imrie, C. W., Carter, C. R., McKay, C. J., & McMillan, D. C. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2370-y · Cited by 60
Cited by
The immune landscape of esophageal cancer
Huang, T.-X., & Fu, L. (2019) · Cancer Communications · doi:10.1186/s40880-019-0427-z · Cited by 262
5T4 oncofoetal glycoprotein: an old target for a novel prostate cancer immunotherapy
Cappuccini, F., Pollock, E., Stribbling, S., Hill, A. V. S., & Redchenko, I. (2017) · Oncotarget · doi:10.18632/oncotarget.17666 · Cited by 31
McCain, R. S., McManus, D. T., McQuaid, S., James, J. A., Salto-Tellez, M., Reid, N. B., Craig, S., Chisambo, C., Bingham, V., McCarron, E., et al. (2020) · Cancer Causes & Control · doi:10.1007/s10552-019-01247-2 · Cited by 28
Cho, J. H., & Lim, Y. C. (2021) · Oral Oncology · doi:10.1016/j.oraloncology.2020.105084 · Cited by 27
Metadata
- Authors
- Noble, F., Mellows, T., McCormick Matthews, L. H., Bateman, A. C., Harris, S., Underwood, T. J., Byrne, J. P., Bailey, I. S., Sharland, D. M., Kelly, J. J., Primrose, J. N., Sahota, S. S., Bateman, A. R., Thomas, G. J., & Ottensmeier, C. H.
- Venue
- Cancer Immunology, Immunotherapy
- Published
- 2016-03-28
- Volume
- 65
- Issue
- 6
- Pages
- 651-662
- ISSN
- 0340-7004 (ISSN-L)
- 1432-0851
- OpenAlex
- W2334750499
- Cited by
- 109
- References
- 2
- FWCI
- 11.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma. https://app.cochat.ai/papers/10.1007/s00262-016-1826-5
- The paper
- Noble, F., Mellows, T., McCormick Matthews, L. H., Bateman, A. C., Harris, S., Underwood, T. J., Byrne, J. P., Bailey, I. S., Sharland, D. M., Kelly, J. J., Primrose, J. N., Sahota, S. S., Bateman, A. R., Thomas, G. J., & Ottensmeier, C. H. (2016). Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-016-1826-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.